Axogen Reports Preliminary Unaudited Revenue for Fourth

ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...

Related Keywords

United States ,South Korea ,Spain ,Russia ,Canada ,Ukraine ,United Kingdom ,Germany ,Haroldd Tamayo ,Karen Zaderej ,Nasdaq ,Axogen Inc ,Unaudited Fourth Quarter ,Year End Performance ,Core Accounts ,Nerve Graft ,Soft Tissue ,Avive Soft Tissue ,Axoguard Nerve ,Nerve Protector ,Private Securities Litigation Reform Act ,Middle East ,Annual Report ,Quarterly Report ,Nasdaq Axgn ,Axogen ,Nc ,Allograft ,Financial Results ,Fourth Quarter ,Vance ,Nxgn ,